Skip to main content
Media Coverage

Psilocin prodrug receives USPTO development approval [Psychedelic Health]

By November 2, 2023No Comments

Enveric Biosciences has received a Notice of Allowance (NoA) from the United States Patent and Trademark Office (USPTO) for a patent application involving EB-373, the company’s new chemical entity (NCE) prodrug of psilocin.

Full Article